Advertisement

Topics

Gerresheimer Group GmbH Company Profile

08:45 EDT 25th September 2018 | BioPortfolio

The Gerresheimer Group is a leading international specialist in high-quality packaging and system approaches, particularly for the pharmaceutics and cosmetics industries. The company develops and manufactures a comprehensive product range of products made of tubular glass and special container glass, as well as packaging and application systems made of glass and plastic. State-of-the-art technologies are used to meet the most demanding customer requirements in terms of quality and precision.

Location

Benrather Straße 18-20
Düsseldorf
D-40213
Germany

Contact

Phone: 49 (0)211 / 6181-251
Fax: 49 (0)211 / 6181-241
Email: b.lingenberg@gerresheimer.com


News Articles [960 Associated News Articles listed on BioPortfolio]

Gerresheimer: Umsatzwachstum soll sich durch neues Geschäftsfeld mittelfristig beschleunigen - Kaufen!

Frankfurt am Main (www.aktiencheck.de) - Gerresheimer-Aktienanalyse von Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktien...

DGAP-Stimmrechte: Gerresheimer AG (deutsch)

Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: Gerresheimer AG Gerresheimer AG: Veröffentlichung gemäß § 40 Abs....

Gerresheimer: Vorgelegte Geschäftszahlen und Übernahme treiben den Kurs an!

Zu den größten Gewinnern im MDAX zählte zuletzt die Aktie des deutschen Verpackungsspezialisten Gerresheimer AG (früher: Gerresheimer Glas). Anscheinend konnten sowohl die vorgelegten Geschäftsza...

DGAP-News: Gerresheimer AG: Gerresheimer steigert Ergebnis je Aktie im ersten Quartal aufgrund US-Steuerreform (deutsch)

Gerresheimer AG: Gerresheimer steigert Ergebnis je Aktie im ersten Quartal aufgrund US-Steuerreform DGAP-News: Gerresheimer AG / Schlagwort(e): Quartals-/Zwischenmitteilung Gerresheimer AG: Gerres...

Gerresheimer AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

Gerresheimer AG / Preliminary announcement on the disclosure of financial statements 29.03.2018 / 16:35 Preliminary announcement of the publication of quarterly reports and quarterly/interim statemen...

Gerresheimer AG Aktie: Kaufen - Trendwechsel nach oben vollzogen!

Chartanalyse der Gerresheimer AG - Aktie Die Gerresheimer AG Aktie bewegte sich in einem intakten Abwärtstrendkanal, in dessen Verlauf sie nach oben ausgebrochen ist. Dieser Ausbruch verbunden mit...

Gerresheimer expands production of pharmaceutical plastic packaging in Brazil

Gerresheimer, the leading manufacturer of specialist packaging for drugs, is further expanding its strong presence on the South American market. The new Gerresheimer Anápolis plant has commenced pro...

DGAP-News: Gerresheimer AG: Dietmar Siemssen wird Vorstandsvorsitzender der Gerresheimer AG (deutsch)

Gerresheimer AG: Dietmar Siemssen wird Vorstandsvorsitzender der Gerresheimer AG DGAP-News: Gerresheimer AG / Schlagwort(e): Personalie Gerresheimer AG: Dietmar Siemssen wird Vorstandsvorsitzender...

PubMed Articles [1743 Associated PubMed Articles listed on BioPortfolio]

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Group Influences on Engaging Self-Control: Children Delay Gratification and Value It More When Their In-Group Delays and Their Out-Group Doesn't.

Self-control emerges in a rich sociocultural context. Do group norms around self-control influence the degree to which children use it? We tested this possibility by assigning 3- to 5-year-old childre...

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Clinical Trials [3959 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Topography-Guided Customized PRK Versus Q-value Adjusted PRK in Correction of Myopia With or Without Astigmatism

This study will include patients who will undergo PRK in both eyes, for each patient each eye will be randomly allocated to one of 2 procedures: topography-guided ablation in one eye (gro...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%

Eligible patients underwent evaluation of ocular surface parameters by Ocular Surface Disease Index (OSDI) and Glaucoma Symptom Scale (GSS) questionnaires, Break Up Time test (BUT), Schirm...

Companies [2160 Associated Companies listed on BioPortfolio]

Gerresheimer Group GmbH

The Gerresheimer Group is a leading international specialist in high-quality packaging and system approaches, particularly for the pharmaceutics and cosmetics industries. The company develops and manu...

Gerresheimer AG

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma & healthcare industry. Our wide product spectrum ranges f...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "Gerresheimer Group GmbH" on BioPortfolio

We have published hundreds of Gerresheimer Group GmbH news stories on BioPortfolio along with dozens of Gerresheimer Group GmbH Clinical Trials and PubMed Articles about Gerresheimer Group GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gerresheimer Group GmbH Companies in our database. You can also find out about relevant Gerresheimer Group GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record